Answers are grounded in this paper and cite their sources.
This commentary emphasizes the necessity of tailored suppressive antibiotic therapy for LVAD versus CIED infections due to their distinct clinical and microbiological characteristics.
A distinction between infections of left ventricular assist devices and cardiac implantable electronic devices is warranted as they differ markedly in incidence, microbiologic profiles, clinical presentations, and extraction feasibility. These differences necessitate tailored suppressive antibiotic therapy (SAT) strategies. This commentary highlights the need for device-specific SAT approaches.
No takes yet. Share an insight, caveat, or question.
Chesdachai et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: